Advertisement

Infection

, Volume 38, Issue 5, pp 427–429 | Cite as

Lemierre syndrome caused by co-infection by Arcanobacterium haemolyticum and Fusobacterium necrophorum

  • K. LundblomEmail author
  • K. Jung
  • M. Kalin
Correspondence

In 1936, Lemierre described a series of cases with anaerobic sepsis following primary oropharyngeal infection. These ‘postanginal septicemias’, subsequently denoted ‘Lemierre syndrome’ or ‘Lemierre’s disease’, were characterized by septic thrombophlebitis of the jugular venous system and multiple metastatic abscesses which were most commonly found in the lungs. The syndrome had a high case-fatality rate and affected mainly young adults [1]. Although polymicrobial infections have been reported, the main pathogen in Lemierre syndrome is Fusobacterium necrophorum, an obligate anaerobic, Gram-negative rod [2]. Disseminated infections are rare. The highest incidence occurs in the age group 15–24 years [3].

Arcanobacterium haemolyticum is an aerobic Gram-positive rod known to cause pharyngotonsillitis and skin rash, predominantly in adolescents and young adults [4, 5]. Deep-seated and systemic infections have been reported occasionally, and to the best of our knowledge only one case of...

Keywords

Human Immunodeficiency Virus Sore Throat Blood Culture Bottle Fusobacterium Necrophorum Septic Thrombophlebitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

We acknowledge Dr. Prathap Solomon for radiological expertise.

Conflict of interest

None.

References

  1. 1.
    Lemierre A. On certain septicemias due to anaerobic organisms. Lancet. 1936;1:701–3.CrossRefGoogle Scholar
  2. 2.
    Sinave CP, Hardy GJ, Fardy PW. The Lemierre syndrome: suppurative thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection. Medicine (Baltimore). 1989;68:85–94.Google Scholar
  3. 3.
    Hagelskjaer Kristensen L, Prag J. Lemierre’s syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey. Eur J Clin Microbiol Infect Dis. 2008;27:779–89.CrossRefPubMedGoogle Scholar
  4. 4.
    Linder R. Rhodococcus equi and Arcanobacterium haemolyticum: two “coryneform” bacteria increasingly recognized as agents of human infection. Emerg Infect Dis. 1997;3:145–53.CrossRefPubMedGoogle Scholar
  5. 5.
    Mackenzie A, Fuite LA, Chan FT, et al. Incidence and pathogenicity of Arcanobacterium haemolyticum during a 2-year study in Ottawa. Clin Infect Dis. 1995;21:177–81.PubMedGoogle Scholar
  6. 6.
    Younus F, Chua A, Tortora G, Jimenez VE. Lemierre’s disease caused by co-infection of Arcanobacterium haemolyticum and Fusobacterium necrophorum: a case report. J Infect. 2002;45:114–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Ludlam H, Howard J, Kingston B, et al. Epidemiology of pharyngeal carriage of Fusobacterium necrophorum. J Med Microbiol. 2009;58:1264–5.CrossRefPubMedGoogle Scholar
  8. 8.
    Hagelskjær L, Kristensen JP. Localised Fusobacterium necrophorum infections: a prospective laboratory-based Danish study. Eur J Clin Microbiol Infect Dis. 2008;27:733–9.CrossRefGoogle Scholar
  9. 9.
    Therriault BL, Daniels LM, Carter YL, Raasch RH. Severe sepsis caused by Arcanobacterium haemolyticum: a case report and review of the literature. Ann Pharmacother. 2008;42:1697–702.CrossRefPubMedGoogle Scholar

Copyright information

© Urban & Vogel 2010

Authors and Affiliations

  1. 1.Department of Medicine Solna, Infectious Diseases Unit, Centre for Molecular MedicineKarolinska InstituteStockholmSweden
  2. 2.Department of Clinical MicrobiologyKarolinska University LaboratoryStockholmSweden

Personalised recommendations